Product Information
GABAPENTIN 250 MG/5 ML SOLN is a generic product labeled by Amneal Pharmaceuticals LLC, priced at $0.1712 per ML under NDC 65162069890. Its NADAC has been published 527 times since Nov 28, 2013.
FDA first approved this application on Mar 23, 2012. Its Orange Book therapeutic-equivalence code is AA.
Strength
250 mg/5mL
Manufacturer
Amneal Pharmaceuticals LLCNDC
65162069890
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
2/18/2026
Active Ingredients
GABAPENTINApproval Type
Generic (ANDA)
FDA Application
ANDA202024FDA Approved
3/23/2012
TE Code
AA
On Market Since
9/30/2011
Pharmacological Classes
Price Statistics
The NADAC for GABAPENTIN 250 MG/5 ML SOLN has been published 527 times since Nov 28, 2013, and over the history we have for it it has risen 9.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1712 per ML |
|---|---|
| All-time high | $0.1957 (Jun 11, 2014) |
| All-time low | $0.0820 (Feb 17, 2016) |
| 52-week high | $0.1712 |
| 52-week low | $0.1658 |
| Median price | $0.1663 |
| Average price | $0.1534 |
| Largest weekly change | +57.7% (Jan 18, 2017) |
| Weeks tracked | 527 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 49% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Gabapentin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GABAPENTIN 250 MG/5 ML SOLN?
The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 250 MG/5 ML SOLN, manufactured by Amneal Pharmaceuticals LLC, is $0.1712 per ML (NDC 65162069890), effective Sep 30, 2026.
How has the price of GABAPENTIN 250 MG/5 ML SOLN changed over time?
Over the history we have for it, the NADAC for GABAPENTIN 250 MG/5 ML SOLN has risen 9.3%. It has been tracked across 527 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for GABAPENTIN 250 MG/5 ML SOLN?
Since Nov 28, 2013, the NADAC for GABAPENTIN 250 MG/5 ML SOLN has ranged from a low of $0.0820 (Feb 17, 2016) to a high of $0.1957 (Jun 11, 2014), with a median of $0.1663 per ML.
Are there cheaper alternatives to GABAPENTIN 250 MG/5 ML SOLN?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GABAPENTIN 250 MG/5 ML SOLN, is $0.0876 per ML — about 49% below GABAPENTIN 250 MG/5 ML SOLN.
Who manufactures GABAPENTIN 250 MG/5 ML SOLN?
GABAPENTIN 250 MG/5 ML SOLN (NDC 65162069890) is labeled by Amneal Pharmaceuticals LLC, and CMS classifies it as a generic product.